Theophylline is able to partially revert cachexia in tumour-bearing rats

dc.contributor.authorOlivan Riera, Mireia
dc.contributor.authorSpringer, Jochen
dc.contributor.authorBusquets Rius, Sílvia
dc.contributor.authorTschirner, Anika
dc.contributor.authorFigueras, Maite
dc.contributor.authorToledo Soler, Miriam
dc.contributor.authorFontes de Oliveira, Cibely Cristine
dc.contributor.authorGenovese, Maria Inês
dc.contributor.authorVentura da Silva, Paula
dc.contributor.authorSette, Angelica
dc.contributor.authorLópez-Soriano, Francisco J.
dc.contributor.authorAnker, Stefan
dc.contributor.authorArgilés Huguet, Josep Ma.
dc.date.accessioned2020-07-08T12:30:01Z
dc.date.available2020-07-08T12:30:01Z
dc.date.issued2012-08-21
dc.date.updated2020-07-08T12:30:01Z
dc.description.abstractBackground and aims: the aim of the present investigation was to examine the anti-wasting effects of theophylline (a methylxantine present in tea leaves) on a rat model of cancer cachexia. Methods: the in vitro effects of the nutraceuticals on proteolysis were examined on muscle cell cultures submitted to hyperthermia. Individual muscle weights, muscle gene expression, body composition and cardiac function were measured in rats bearing the Yoshida AH-130 ascites hepatoma, following theophylline treatment. Results: Theophylline treatment inhibited proteolysis in C2C12 cell line and resulted in an anti-proteolytic effect on muscle tissue (soleus and heart), which was associated with a decrease in circulating TNF-alpha levels and with a decreased proteolytic systems gene expression. Treatment with the nutraceutical also resulted in an improvement in body composition and cardiac function. Conclusion: Theophylline - alone or in combination with drugs - may be a candidate molecule for the treatment of cancer cachexia.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec620454
dc.identifier.issn1743-7075
dc.identifier.pmid22909172
dc.identifier.urihttps://hdl.handle.net/2445/168103
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/1743-7075-9-76
dc.relation.ispartofNutrition and Metabolism, 2012, vol. 9, num. 1, p. 76
dc.relation.urihttps://doi.org/10.1186/1743-7075-9-76
dc.rightscc-by (c) Olivan Riera, Mireia et al., 2012
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationTeofil·lina
dc.subject.classificationCaquèxia
dc.subject.classificationRatolins (Animals de laboratori)
dc.subject.otherTheophylline
dc.subject.otherCachexia
dc.subject.otherMice (Laboratory animals)
dc.titleTheophylline is able to partially revert cachexia in tumour-bearing rats
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
620454.pdf
Mida:
434.54 KB
Format:
Adobe Portable Document Format